Barclays has downgraded FMC Corp (FMC) to Underweight from Equal-Weight, reflecting increased caution regarding the company's outlook. The change, effective December 8, 2025, comes as FMC Corp faces potential competitive pressures and market challenges.
FMC Corp, headquartered in Philadelphia, operates in the agricultural sciences sector, offering solutions for crop protection, plant health, and pest control. The company employs approximately 5,700 full-time staff and has a market capitalization of $1.6 billion. As of November 20, 2025, FMC's stock price stands at $14.18, with a trailing twelve-month EPS of -4.27 and an extraordinary dividend yield of 1828.2%.
Analysts currently hold a consensus rating of Hold for FMC, with 3 Strong Buy, 5 Buy, 16 Hold, 0 Sell, and 1 Strong Sell ratings among 25 total analysts. Upcoming earnings are scheduled for July 28, 2026, with an estimated EPS of $0.58 and revenue of $1.0 billion.
This update provides insight into the shifting sentiment surrounding FMC Corp, as analyst ratings can evolve with new information and varying perspectives.